About Cell-Easy
Cell-Easy is a company based in Toulouse (France) founded in 2015 by Guillaume Costecalde and Benedikt Timmerman.. Cell-Easy offers products and services including GMP Cell Banking, ATMP Manufacturing, Pharma Development, and MSC Transfer. Cell-Easy operates in a competitive market with competitors including Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Genflow Biosciences, among others.
- Headquarter Toulouse, France
- Founders Guillaume Costecalde, Benedikt Timmerman
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cell-Easy Sas
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Merieux Equity Partners
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cell-Easy
Cell-Easy offers a comprehensive portfolio of products and services, including GMP Cell Banking, ATMP Manufacturing, Pharma Development, and MSC Transfer. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for storing and managing cell banks under GMP standards.
Manufactures advanced therapy medicinal products for clinical use.
Supports optimization and scale-up of cell therapy processes.
Facilitates mesenchymal stem cell transfer and related services.
Unlock access to complete
Unlock access to complete
Funding Insights of Cell-Easy
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Series A - Cell-Easy | Valuation | Merieux Equity Partners , M Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cell-Easy
Cell-Easy has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Merieux Equity Partners, M Capital and IRDI Capital Investissement. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pivate equity firm that focuses on investing in healthcare and nutrition companies
|
Founded Year | Domain | Location | |
|
Investment solutions are provided by M Capital for various sectors.
|
Founded Year | Domain | Location | |
|
Investment services are provided to startups, SMEs, and ETI in South-West France.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cell-Easy
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cell-Easy
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cell-Easy Comparisons
Competitors of Cell-Easy
Cell-Easy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Genflow Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell and gene therapies for multiple disorders are developed.
|
|
| domain | founded_year | HQ Location |
Software development services are provided for the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Services for cell therapy development and manufacturing are provided.
|
|
| domain | founded_year | HQ Location |
Development and manufacturing services for cell-based therapies are provided.
|
|
| domain | founded_year | HQ Location |
A biotechnology company focused on anti-aging therapeutics development.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cell-Easy
Frequently Asked Questions about Cell-Easy
When was Cell-Easy founded?
Cell-Easy was founded in 2015 and raised its 1st funding round 5 years after it was founded.
Where is Cell-Easy located?
Cell-Easy is headquartered in Toulouse, France. It is registered at Toulouse, Occitanie, France.
What does Cell-Easy do?
Cell-Easy was established in 2015 in Toulouse, France, within the biotechnology sector. Services centered on stem cell-based therapy for research applications are delivered. Allogeneic stem cells sourced from adipose tissue and prepared for injection are developed to support preclinical and clinical phases of drug development. Operations emphasize ready-to-use solutions for therapeutic research.
Who are the top competitors of Cell-Easy?
Cell-Easy's top competitors include Ori Biotech, MaSTherCell and Genflow Biosciences.
What products or services does Cell-Easy offer?
Cell-Easy offers GMP Cell Banking, ATMP Manufacturing, Pharma Development, and MSC Transfer.
Who are Cell-Easy's investors?
Cell-Easy has 3 investors. Key investors include Merieux Equity Partners, M Capital, and IRDI Capital Investissement.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.